CHICAGO, April 24, 2024 /PRNewswire/ -- CME Group Inc. (NASDAQ: CME) today reported financial results for the first quarter of 2024.

The company reported revenue of $1.5 billion and operating income of $960 million for the first quarter of 2024. Net income was $855 million and diluted earnings per common share were $2.35. On an adjusted basis, net income was $911 million and diluted earnings per common share were $2.50. Financial results presented on an adjusted basis for the first quarter of 2024 and 2023 exclude certain items, which are detailed in the reconciliation of non-GAAP results.1

"CME Group adjusted net income and earnings per share reached new records in Q1 as investors turned to our markets to manage through the ongoing economic and geopolitical uncertainty in today's marketplace," said Terry Duffy, CME Group Chairman and Chief Executive Officer. "Average daily volume in our U.S. Treasury futures and options grew 12% year over year, reaching a new all-time high of 7.8 million contracts per day. Additionally, ADV in our commodities markets increased 14% to 4.7 million contracts. Looking ahead, we remain committed to providing the deep liquidity and unparalleled capital efficiencies our clients rely on as they continue to navigate a wide range of risks across asset classes."

First-quarter 2024 average daily volume (ADV) was 26.4 million contracts, including non-U.S. ADV, which reached a record 7.4 million contracts.

1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of GAAP to non-GAAP Measures chart at the end of the financial statements and earnings presentation materials.

Clearing and transaction fees revenue for first-quarter 2024 totaled $1.2 billion. The total average rate per contract was $0.695. Market data revenue totaled $175 million for first-quarter 2024.

As of March 31, 2024, the company had approximately $1.7 billion in cash (including $225 million deposited with Fixed Income Clearing Corporation, which is included in other current assets) and $3.4 billion of debt. The company paid dividends during the first quarter of approximately $2.3 billion. The company has returned approximately $24.8 billion to shareholders in the form of dividends since the implementation of the variable dividend policy in early 2012.

CME Group will hold a Q&A conference call to discuss first-quarter 2024 results at 8:30 a.m. Eastern Time today. A live audio webcast of the Q&A call will be available on the Investor Relations section of CME Group's website at www.cmegroup.com. An archived recording will be available for up to two months after the call.

As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing. 

CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and, E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. BrokerTec and EBS are trademarks of BrokerTec Europe LTD and EBS Group LTD, respectively. The S&P 500 Index is a product of S&P Dow Jones Indices LLC ("S&P DJI"). "S&P®", "S&P 500®", "SPY®", "SPX®", US 500 and The 500 are trademarks of Standard & Poor's Financial Services LLC; Dow Jones®, DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc. Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products. All other trademarks are the property of their respective owners.

Statements in this press release that are not historical facts are forward-looking statements.  These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Among the factors that might affect our performance are increasing competition by foreign and domestic entities, including increased competition from new entrants into our markets and consolidation of existing entities; our ability to keep pace with rapid technological developments, including our ability to complete the development, implementation and maintenance of the enhanced functionality required by our customers while maintaining reliability and ensuring that such technology is not vulnerable to security risks; our ability to continue introducing competitive new products and services on a timely, cost-effective basis, including through our electronic trading capabilities, and our ability to maintain the competitiveness of our existing products and services; our ability to adjust our fixed costs and expenses if our revenues decline; our ability to maintain existing customers at substantially similar trading levels, develop strategic relationships and attract new customers; our ability to expand and globally offer our products and services; changes in regulations, including the impact of any changes in laws or government policies with respect to our products or services or our industry, such as any changes to regulations and policies that require increased financial and operational resources from us or our customers; the costs associated with protecting our intellectual property rights and our ability to operate our business without violating the intellectual property rights of others; decreases in revenue from our market data as a result of decreased demand or changes to regulations in various jurisdictions; changes in our rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer receives member or non-member fees or participates in one of our various incentive programs) and the impact of our tiered pricing structure; the ability of our credit and liquidity risk management practices to adequately protect us from the credit risks of clearing members and other counterparties, and to satisfy the margin and liquidity requirements associated with the BrokerTec matched principal business; the ability of our compliance and risk management programs to effectively monitor and manage our risks, including our ability to prevent errors and misconduct and protect our infrastructure against security breaches and misappropriation of our intellectual property assets; our dependence on third-party providers and exposure to risk through third parties, including risks related to the performance, reliability and security of technology used by our third-party providers and third-party providers that our clients rely on; volatility in commodity, equity and fixed income prices, and price volatility of financial benchmarks and instruments such as interest rates, equity indices, fixed income instruments and foreign exchange rates; economic, social, political and market conditions, including the volatility of the capital and credit markets and the impact of economic conditions on the trading activity of our current and potential customers; our ability to accommodate increases in contract volume and order transaction traffic and to implement enhancements without failure or degradation of the performance of our trading and clearing systems; our ability to execute our growth strategy and maintain our growth effectively; our ability to manage the risks, control the costs and achieve the synergies associated with our strategy for acquisitions, investments and alliances, including those associated with the performance of our joint ventures with S&P Dow Jones (S&P Dow Jones Indices LLC) in index services and in trade processing/post trade services (OSTTRA), our primary business and distribution partners' actions and our partnership with Google Cloud; variances in earnings on cash accounts and collateral that our clearing house holds for its clients; impact of CME Group pricing and incentive changes; impact of aggregation services and internalization on trade flow and volumes; any negative financial impacts from changes to the terms of intellectual property and index rights; our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to invest in our business; industry, channel partner and customer consolidation and/or concentration; decreases in trading and clearing activity; the imposition of a transaction tax or user fee on futures and options transactions and/or repeal of the 60/40 tax treatment of such transactions; increases in effective tax rates, borrowing costs, or changes in tax policy; our ability to maintain our brand and reputation; and the unfavorable resolution of material legal proceedings.  For a detailed discussion and additional information concerning these and other factors that might affect our performance, see our other recent periodic filings, including our Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission ("SEC") on February 28, 2024, under the caption "Risk Factors."

 

CME Group Inc. and Subsidiaries

Consolidated Balance Sheets

(in millions)




March 31, 2024


December 31, 2023

ASSETS





Current Assets:





Cash and cash equivalents


$                 1,436.9


$                 2,912.0

Marketable securities


121.0


111.7

Accounts receivable, net of allowance


628.2


535.6

Other current assets (includes $5.2 in restricted cash)


647.7


1,138.4

Performance bonds and guaranty fund contributions


94,473.9


90,192.5

Total current assets


97,307.7


94,890.2

Property, net of accumulated depreciation and amortization


396.0


409.5

Intangible assets—trading products


17,175.3


17,175.3

Intangible assets—other, net


2,990.0


3,050.2

Goodwill


10,489.6


10,495.3

Other assets


3,695.1


3,685.6

Total Assets


$             132,053.7


$             129,706.1

LIABILITIES AND EQUITY





Current Liabilities:





Accounts payable


$                     111.0


$                       90.6

Short-term debt


749.3


Other current liabilities


767.2


3,133.8

Performance bonds and guaranty fund contributions


94,473.9


90,192.5

Total current liabilities


96,101.4


93,416.9

Long-term debt


2,676.7


3,425.4

Deferred income tax liabilities, net


5,317.2


5,327.7

Other liabilities


804.2


798.2

Total Liabilities


104,899.5


102,968.2

Total CME Group Shareholders' Equity


27,154.2


26,737.9

Total Liabilities and Equity


$             132,053.7


$             129,706.1

 

CME Group Inc. and Subsidiaries

Consolidated Statements of Income

(dollars in millions, except per share amounts; shares in thousands)




Quarter Ended

March 31,



2024


2023

Revenues





Clearing and transaction fees


$  1,208.9


$  1,200.2

Market data and information services


175.4


165.8

Other


103.6


75.6

Total Revenues


1,487.9


1,441.6

Expenses





Compensation and benefits


206.0


204.5

Technology


59.4


51.3

Professional fees and outside services


33.1


38.3

Amortization of purchased intangibles


55.2


56.8

Depreciation and amortization


30.1


31.9

Licensing and other fee agreements


87.9


84.7

Other


56.6


60.4

Total Expenses


528.3


527.9

Operating Income


959.6


913.7

Non-Operating Income (Expense)





Investment income


1,071.3


1,357.7

Interest and other borrowing costs


(39.9)


(39.9)

Equity in net earnings of unconsolidated subsidiaries


87.2


78.2

Other non-operating income (expense)


(964.8)


(1,152.8)

Total Non-Operating Income (Expense)


153.8


243.2

Income before Income Taxes


1,113.4


1,156.9

Income tax provision


258.2


273.1

Net Income


$      855.2


$      883.8

Net Income Attributable to Common Shareholders of CME Group


$      844.4


$      872.7






Earnings per Share Attributable to Common Shareholders of CME Group:





Basic


$        2.35


$        2.43

Diluted


2.35


2.43

Weighted Average Number of Common Shares:





Basic


359,258


358,933

Diluted


359,833


359,313

 

CME Group Inc. and Subsidiaries
Quarterly Operating Statistics




1Q 2023


2Q 2023


3Q 2023


4Q 2023


1Q 2024

Trading Days


62


62


63


63


61

 

Quarterly Average Daily Volume (ADV)(1)
CME Group ADV (in thousands)


Product Line


1Q 2023


2Q 2023


3Q 2023


4Q 2023


1Q 2024

Interest rates


14,490


11,273


10,967


13,348


13,839

Equity indexes


7,303


6,216


6,353


6,922


6,856

Foreign exchange


969


898


942


1,007


984

Energy


2,083


2,104


2,126


2,158


2,412

Agricultural commodities


1,379


1,752


1,433


1,469


1,596

Metals


649


612


528


609


675

Total


26,873


22,855


22,349


25,513


26,360

Venue











CME Globex


24,171


20,907


20,838


23,503


23,985

Open outcry


1,623


1,124


713


1,126


1,333

Privately negotiated


1,080


825


797


885


1,043

Total


26,873


22,855


22,349


25,513


26,360















 

Quarterly Average Rate Per Contract (RPC)(1)
CME Group RPC


Product Line


1Q 2023


2Q 2023


3Q 2023


4Q 2023


1Q 2024

Interest rates


$          0.495


$          0.505


$          0.508


$          0.488


$          0.486

Equity indexes


0.595


0.644


0.625


0.616


0.641

Foreign exchange


0.790


0.800


0.791


0.806


0.787

Energy


1.300


1.347


1.324


1.338


1.334

Agricultural commodities


1.349


1.356


1.328


1.361


1.356

Metals


1.517


1.487


1.492


1.502


1.556

Average RPC


$          0.664


$          0.724


$          0.707


$          0.682


$          0.695












1. ADV and RPC includes futures and options on futures only.



 

CME Group Inc. and Subsidiaries

Reconciliation of GAAP to non-GAAP Measures

(dollars in millions, except per share amounts; shares in thousands)








Quarter Ended

March 31,



2024


2023

Net Income


$      855.2


$      883.8

Restructuring and severance


2.8


0.7

Amortization of purchased intangibles(1)


68.7


70.1

Strategic transaction-related costs (credits)


1.9


(2.2)

Foreign exchange transaction (gains) losses


(1.8)


0.7

Unrealized and realized (gains) losses on investments


(2.5)


(74.8)

Unrealized and realized (gains) losses on assets


0.8


Income tax effect related to above


(14.0)


4.0

Adjusted Net Income


$      911.1


$      882.3






Adjusted Net Income Attributable to Common Shareholders of CME Group


$      899.7


$      871.1






Earnings per Share Attributable to Common Shareholders of CME Group:




     Basic


$        2.35


$        2.43

     Diluted


2.35


2.43






Adjusted Earnings per Share Attributable to Common Shareholders of CME Group:




     Basic


$        2.50


$        2.43

     Diluted


2.50


2.42






Weighted Average Number of Common Shares:





     Basic


359,258


358,933

     Diluted


359,833


359,313

Preferred shares(2)


4,584


4,584






1. Includes $11.1 million of amortization of purchased intangibles (net of tax) at OSTTRA and $2.4 million of amortization of purchased intangibles
at S&P Dow Jones Indices LLC, reported in Equity in net earnings of unconsolidated subsidiaries on the Consolidated Statements of Income.

2. Preferred shares have similar rights as common shares without voting rights.

 

CME-G

 

Cision View original content:https://www.prnewswire.com/news-releases/cme-group-inc-reports-first-quarter-2024-financial-results-302125587.html

SOURCE CME Group

Copyright 2024 PR Newswire

CME (NASDAQ:CME)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more CME Charts.
CME (NASDAQ:CME)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more CME Charts.